* Heartbeam Inc BEAT.OQ reported a quarterly adjusted loss
of 19
cents per share for the quarter , lower than the same quarter
last year, when the company reported EPS of -13 cents. The mean
expectation of two analysts for the quarter was for a loss of 17
cents per share. Wall Street expected results to range from -18
cents to -17 cents per share.
* Reported revenue was zero; analysts expected zero.
* Heartbeam Inc's reported EPS for the quarter was a loss
of 19
cents.
* The company reported a quarterly loss of $4.98 million.
* Heartbeam Inc shares had risen by 0.4% this quarter and
lost 0.9% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 6.1%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is "hold."
Wall Street's median 12-month price target for Heartbeam Inc is
5.00
This summary was machine generated from LSEG data November 8 at
09:01 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.17 -0.19 Missed
Jun. 30 2024 -0.16 -0.19 Missed
Mar. 31 2024 -0.15 -0.17 Missed
Dec. 31 2023 -0.13 -0.15 Missed